UTHR vs. AEVA
UTHR (United Therapeutics Corporation) and AEVA (Aeva Technologies, Inc.) are both stocks. UTHR operates in Biotechnology (Healthcare), while AEVA operates in Auto Parts (Consumer Cyclical). Over the past 5 years, UTHR returned 25.53%/yr vs -16.40%/yr for AEVA. At a 0.13 correlation, their price movements are largely independent.
Performance
UTHR vs. AEVA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UTHR achieves a 11.79% return, which is significantly lower than AEVA's 73.87% return.
UTHR
- 1D
- -0.94%
- 1M
- -3.58%
- YTD
- 11.79%
- 6M
- 13.59%
- 1Y
- 67.18%
- 3Y*
- 33.59%
- 5Y*
- 25.53%
- 10Y*
- 17.20%
AEVA
- 1D
- 0.35%
- 1M
- 70.15%
- YTD
- 73.87%
- 6M
- 53.02%
- 1Y
- 10.48%
- 3Y*
- 49.22%
- 5Y*
- -16.40%
- 10Y*
- —
UTHR vs. AEVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
UTHR United Therapeutics Corporation | 11.79% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 43.46% |
AEVA Aeva Technologies, Inc. | 73.87% | 179.58% | 25.38% | -44.29% | -82.01% | -48.01% | 51.46% |
Correlation
The correlation between UTHR and AEVA is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Feb 27, 2020 | 0.13 |
Fundamentals
UTHR:
$25.71B
AEVA:
$1.45B
UTHR:
$27.00
AEVA:
-$2.52
UTHR:
8.19
AEVA:
63.51
UTHR:
$3.17B
AEVA:
$20.97M
UTHR:
$2.74B
AEVA:
$971.00K
UTHR:
$1.75B
AEVA:
$21.17M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UTHR vs. AEVA — Risk / Return Rank
UTHR
AEVA
UTHR vs. AEVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Aeva Technologies, Inc. (AEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| UTHR | AEVA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.27 | ||
| Sortino ratioReturn per unit of downside risk | +1.76 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.12 | +0.26 |
| Calmar ratioReturn relative to maximum drawdown | 4.13 | 0.14 | +3.99 |
| Martin ratioReturn relative to average drawdown | 10.54 | 0.19 | +10.35 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| UTHR | AEVA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.36 | 0.09 | +1.27 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.73 | -0.17 | +0.90 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.49 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | -0.12 | +0.51 |
Drawdowns
UTHR vs. AEVA - Drawdown Comparison
The maximum UTHR drawdown since its inception was -93.18%, roughly equal to the maximum AEVA drawdown of -97.71%. Use the drawdown chart below to compare losses from any high point for UTHR and AEVA.
Loading charts...
Drawdown Indicators
| UTHR | AEVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.18% | -97.71% | +4.53% |
Max Drawdown (1Y)Largest decline over 1 year | -16.35% | -75.68% | +59.33% |
Max Drawdown (3Y)Largest decline over 3 years | -33.00% | -75.68% | +42.68% |
Max Drawdown (5Y)Largest decline over 5 years | -33.00% | -96.02% | +63.02% |
Max Drawdown (10Y)Largest decline over 10 years | -55.56% | — | — |
Current DrawdownCurrent decline from peak | -8.73% | -76.91% | +68.18% |
Average DrawdownAverage peak-to-trough decline | -35.31% | -70.68% | +35.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.39% | 55.91% | -49.52% |
Volatility
UTHR vs. AEVA - Volatility Comparison
The current volatility for United Therapeutics Corporation (UTHR) is 5.15%, while Aeva Technologies, Inc. (AEVA) has a volatility of 39.11%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than AEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UTHR | AEVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.15% | 39.11% | -33.96% |
Volatility (6M)Calculated over the trailing 6-month period | 26.01% | 78.74% | -52.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.84% | 114.82% | -64.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.13% | 97.00% | -61.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.07% | 91.35% | -56.28% |
Dividends
UTHR vs. AEVA - Dividend Comparison
Neither UTHR nor AEVA has paid dividends to shareholders.
Financials
UTHR vs. AEVA - Financials Comparison
This section allows you to compare key financial metrics between United Therapeutics Corporation and Aeva Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
UTHR and AEVA have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AEVA has higher volatility (39.11%) compared to UTHR (5.15%). In terms of maximum drawdown, UTHR dropped -93.18% vs AEVA's -97.71%.
UTHR currently has the higher Sharpe Ratio (1.36 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UTHR and AEVA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer